1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
Prefilled Syringes Market by Material, by Design, by Application, by Geography - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023

Prefilled Syringes Market by Material, by Design, by Application, by Geography - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023

  • October 2018
  • 191 pages
  • ID: 4402315
  • Format: PDF
  • By Prescient & Strategic Intelligence Private Limited

Summary

Table of Contents

Prefilled Syringes Market by Material (Glass, Plastic), by Design (Single-Chamber, Dual-Chamber, Customized), by Application (Diabetes, Rheumatoid Arthritis, Anaphylaxis), by Geography (Germany, France, U.K., Italy, Spain, U.S., Canada, Japan, China, India, Australia, New Zealand, Brazil, Mexico, South Africa, Saudi Arabia) - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023

Prefilled syringes market is expected to attain a size of $7.5 billion by 2023, increasing demand for injectable pharmaceutical products, advanced applications of combination therapies for the management of diseases, rising prevalence of chronic and lifestyle associated diseases, benefits of prefilled syringes over traditional vial and syringe packaging systems, and technological advancements in syringes are the major factors driving the growth of the prefilled syringes market globally.

On the basis of material, the prefilled syringes market has been categorized into glass and plastic material. In 2017, glass syringes held a larger share, of 53.4%, in the global prefilled syringes market. This is characterized by minimal risk of infections with the use of glass-based drug delivery syringes.

Based on design, these products are classified into single-chamber, dual-chamber, and customized syringes. Single-chamber prefilled syringes held the largest share in the global prefilled syringes market, accounting for 77.1% market share in 2017. Wider availability and increasing use of single-chamber syringes are significant factors for the growth of this category, globally.

Prefilled syringe drug delivery systems are frequently used in the treatment of diabetes, rheumatoid arthritis, anaphylaxis, and other diseases, such as multiple sclerosis, anemia, and psoriasis. The application of prefilled syringes for diabetes is expected to lead the global market, advancing at a CAGR of 9.0% during the forecast period. Increasing prevalence of diabetes across the world is the key factor contributing in the growth of the prefilled syringes market. This is substantiated by the fact that, according to the World Health Organization (WHO), the prevalence of diabetes among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014, globally.

During the forecast period, the prefilled syringes market is forecasted to witness the fastest growth in APAC, at a CAGR of 9.6%. This growth is attributed to the rising geriatric population, and surge in the prevalence of different chronic diseases in the region. According to the UN publication, World Population Aging Report 2017, the population aged 60 years and above is expected to increase from 10.0% in 2010 to approximately 25.0% by 2050. This increase in the aging population is expected to create high demand for prefilled syringes, to eliminate the occurrence of various chronic diseases among the aged population.

Moreover, China is expected to observe significant growth in the APAC prefilled syringes market, owing to the presence of large number of local players and growing geriatric population in the country. Moreover, various immunization programs implemented by the Chinese government is also contributing to the growth of market. For instance, the Chinese government implemented Polio Endgame Strategic Plan 2013–2018 to eliminate measles, and minimize hepatitis B cases in the country. Due to increasing immunization programs implemented by the government officials in China, there is a high demand for syringes in the country.

The companies operating in the prefilled syringes industry are getting government approvals for various drugs used in syringes to increase their market share. For instance, in August 2018, Bristol-Myers Squibb Company received United States Food and Drug Administration (USFDA) approval for Opdivo (nivolumab), as the first and only Immuno-Oncology treatment option for patients with metastatic small cell lung cancer (SCLC), whose cancer has progressed after platinum-based chemotherapy.

In the same month, AbbVie Inc. also received USFDA approval for IMBRUVICA (ibrutinib) plus rituximab (RITUXAN) for the treatment of adult patients with Waldenström’s macroglobulinemia (WM), a rare and incurable type of non-Hodgkin’s lymphoma (NHL).

Some of the other key players operating in the prefilled syringes industry are Becton, Dickinson and Company, Eli Lilly and Company, Amgen Inc., Baxter International Inc., Bayer AG, Pfizer Inc., F. Hoffman-La Roche AG, and Novartis AG.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Programmable Infusion Pumps Market by Distribution Channel, Product, and Geography - Forecast and Analysis 2020-2024

Programmable Infusion Pumps Market by Distribution Channel, Product, and Geography - Forecast and Analysis 2020-2024

  • $ 2500
  • December 2019

Global Programmable Infusion Pumps Market: About this marketThis programmable infusion pumps market analysis considers sales from large-volume infusion pumps and small-volume infusion pumps. Our study ...

Global Autoinjectors Industry

Global Autoinjectors Industry

  • $ 4950
  • February 2020

Autoinjectors market worldwide is projected to grow by US$89.1 Billion, driven by a compounded growth of 22.7%. Rheumatoid Arthritis, one of the segments analyzed and sized in this study, displays the ...

Global Amniocentesis Needle Industry

Global Amniocentesis Needle Industry

  • $ 4950
  • February 2020

Amniocentesis Needle market worldwide is projected to grow by US$31.4 Million, driven by a compounded growth of 2.7%. Smaller Than 100 mm, one of the segments analyzed and sized in this study, displays ...

Drug Delivery: Injection Devices $ 4750 December 2019


ref:plp2018

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on